Signed in as:
Signed in as:
National media coverage recently received in Australia.
A group of dedicated professionals working in collaboration with medical and scientific experts worldwide, using clinical trials to assist in the validation of biomarkers in combination with other modalities to definitively diagnose TBI with emphasis on mild TBI (mTBI)/concussion.
With extensive experience in fields covering biomedical sciences, research, diagnostics and commercial development, GLIA is well placed to make much needed, valuable discoveries in this area.
With most product development, individuals and groups tend to work in 'silos', the result being little overall progress. Medical research embarrassingly is no different.
We envisage GLIA as being a 'central hub' between multiple synergistic parties both here in Australasia and worldwide, to maximise individual and group findings, to finally provide an accurate TBI diagnostic.
To increase the understanding of brain related injury with particular emphasis on mTBI through ongoing research and education, and to ultimately robustly validate a device that will be used in combination with other clinical measures as a definitive diagnostic/prognostic tool.
This video provides an overview of GLIA's TBI diagnostic testing technology.
Sign up to hear from us.